Poniard Pharmaceuticals, Inc. (PARD)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Oct 9, 2026
Poniard Pharmaceuticals Market Cap
Poniard Pharmaceuticals has a market cap or net worth of $150 as of October 9, 2026. It is the 52,786th most valuable company in the world and the 8,811th biggest in the United States.
Market Cap
150.00
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,811 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since August 11, 1988, Poniard Pharmaceuticals's market cap has decreased from 100.37M to 150.00, a decrease of -100.00%. That is a compound annual growth rate of -29.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 150.00 | 14,900.00% |
| Dec 30, 2021 | 1.00 | -100.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NanoLogix | 163.00 |
| Kiromic BioPharma | 157.00 |
| Regenicin | 153.00 |
| NexImmune | 139.00 |
| Seelos Therapeutics | 136.00 |
| PsyBio Therapeutics | 133.00 |
| Marizyme | 132.00 |
| HEALTHeUNIVERSE | 118.00 |